Status:
ACTIVE_NOT_RECRUITING
Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
Lead Sponsor:
University of California, Irvine
Conditions:
Prostatic Hyperplasia
Stress Urinary Incontinence
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Holmium laser enucleation of the prostate (HoLEP) is a surgical procedure used to treat benign prostatic hyperplasia (BPH). HoLEP involves the removal of obstructive prostatic tissue via an endoscopic...
Detailed Description
The incidence of benign prostatic hyperplasia (BPH) in men significantly increases with age and is estimated to impact over 80% of men 70 to 80 years of age. HoLEP is one of many treatments for BPH an...
Eligibility Criteria
Inclusion
- Adult males who have lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH) and considering/undergoing HoLEP for LUTS/BPH treatment at the University of California Irvine Medical Center.
- Age \>= 18
- English-speaker
Exclusion
- Non-English speaker
- Having an indwelling catheter preoperatively
- Neurological disorders that might potentially affect muscle function
- Neurogenic bladder
- Lumbosacral spine pathology
- Any condition that can interfere with pelvic muscle function per principal investigator's discretion
Key Trial Info
Start Date :
February 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06209307
Start Date
February 8 2024
End Date
May 31 2026
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Irvine Medical Center
Orange, California, United States, 92868